New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Ceremed Inc.
www.ceremed.com
Latest From Ceremed Inc.
Beyond INFUSE: Spine Community Searches For Answers, Alternatives
Medtronic's INFUSE bone morphogenetic protein is the only product in the musculoskeletal industry that has changed the bar in terms of bone healing, and it is under fire for complications related to off-label use. As regulators and payors crack down on INFUSE and hospitals restrict access to the product, surgeons are seeking alternatives and there are a number of companies lining up to fill the void
Beyond INFUSE: Spine Community Searches For Answers, Alternatives
Medtronic's INFUSE bone morphogenetic protein is the only product in the musculoskeletal industry that has changed the bar in terms of bone healing, and it is under fire for complications related to off-label use. As regulators and payors crack down on INFUSE and hospitals restrict access to the product, surgeons are seeking alternatives and there are a number of companies lining up to fill the void
Deals Update
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Company Information
- Industry
- Biotechnology
-
Medical Devices
- Biomaterials
- Implantable Devices
- Therapeutic Areas
- Blood & Coagulation Disorders & Products
- Musculoskeletal & Connective Tissue Disorders
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Ceremed Inc.
- Senior Management
-
Tadeusz Wellisz, Pres. & CEO
Anthony Ruggiero, VP, Sales & Bus. Dev. - Contact Info
-
Ceremed Inc.
Phone: (310) 815-2125
3643 Lenawee Ave.
Los Angeles, CA 90016
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ceremed Inc.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice